Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial.
Georgoulias V, Ardavanis A, Tsiafaki X, Agelidou A, Mixalopoulou P, Anagnostopoulou O, Ziotopoulos P, Toubis M, Syrigos K, Samaras N, Polyzos A, Christou A, Kakolyris S, Kouroussis C, Androulakis N, Samonis G, Chatzidaki D. Georgoulias V, et al. Among authors: ziotopoulos p. J Clin Oncol. 2005 May 1;23(13):2937-45. doi: 10.1200/JCO.2005.04.016. Epub 2005 Feb 22. J Clin Oncol. 2005. PMID: 15728228 Clinical Trial.
Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: a multicentre phase II study.
Ziotopoulos P, Androulakis N, Mylonaki E, Chandrinos V, Zachariadis E, Boukovinas I, Agelidou A, Kentepozidis N, Ignatiadis M, Vossos A, Georgoulias V; Lung Cancer Committee of the Hellenic Oncology Research Group (HORG). Ziotopoulos P, et al. Lung Cancer. 2005 Oct;50(1):115-22. doi: 10.1016/j.lungcan.2005.05.004. Lung Cancer. 2005. PMID: 15993981 Clinical Trial.
Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.
Makrantonakis P, Ziotopoulos P, Agelidou A, Polyzos A, Ziras A, Chandrinos V, Vossos A, Kalykaki A, Androulakis N, Geroyianni A, Georgoulias V; Lung Cancer Committee of the Hellenic Oncology Research Group. Makrantonakis P, et al. Among authors: ziotopoulos p. Lung Cancer. 2006 Jul;53(1):85-90. doi: 10.1016/j.lungcan.2006.02.008. Epub 2006 May 23. Lung Cancer. 2006. PMID: 16720058 Clinical Trial.
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study.
Mavroudis D, Veslemes M, Kouroussis Ch, Tzanakis N, Ferdoutsis E, Toumbis M, Ziotopoulos P, Agelidou M, Tselepatiotis E, Kalbakis K, Souglakos J, Magkanas E, Samonis G, Georgoulias V; Hellenic Oncology Research Group. Mavroudis D, et al. Among authors: ziotopoulos p. Lung Cancer. 2002 Oct;38(1):59-63. doi: 10.1016/s0169-5002(02)00149-6. Lung Cancer. 2002. PMID: 12367794 Clinical Trial.
Docetaxel versus docetaxel/cisplatin in patients with advanced non-small-cell lung cancer: preliminary analysis of a multicenter, randomized phase III study.
Georgoulias V, Pallis AG, Kourousis C, Alexopoulos A, Ardavanis A, Agelidou A, Agelidou M, Toumbis M, Tzannes S, Pavlakou G, Ziotopoulos P, Tzelepatiotis E, Samaras N. Georgoulias V, et al. Among authors: ziotopoulos p. Clin Lung Cancer. 2003 Mar;4(5):288-93. doi: 10.3816/clc.2003.n.008. Clin Lung Cancer. 2003. PMID: 14609446 Clinical Trial.